Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Sucampo Pharmaceuticals, Inc. (SCMP)

-NasdaqGM
6.06 0.11(1.78%) Jul 28, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 89,594   81,487   54,761  
Cost of Revenue12,402  3,030   -  
Gross Profit 77,192   78,457   54,761  
Operating Expenses
Research Development21,524  21,292  33,497  
Selling General and Administrative46,472  48,848  38,953  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 9,196   8,317   (17,689)
Income from Continuing Operations
Total Other Income/Expenses Net3,045  1,781  (1,770)
Earnings Before Interest And Taxes12,241  10,098  (19,459)
Interest Expense1,894  2,346  2,455  
Income Before Tax10,347  7,752  (21,914)
Income Tax Expense3,928  2,916  (4,608)
Minority Interest -   -   -  
Net Income From Continuing Ops6,419  4,836  (17,306)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 6,419   4,836   (17,306)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 6,419   4,836   (17,306)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.